Tag: biotech
Week in DC: Additional insight into pharma/biotech industries
Our guest speaker from Breakaway Policy Strategies provided additional insight into the pharma/biotech industries and how drug costs, marketing efforts, and FDA activities are impacting the bio-pharma/med device landscape. Some areas of interest included: Although prescription drug costs get a lot of coverage in the media and even though prescription drug costs are growing, they […]